Correlation Between GlaxoSmithKline PLC and Meitav Trade

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Meitav Trade at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Meitav Trade into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Meitav Trade Inv, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Meitav Trade and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Meitav Trade. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Meitav Trade.

Diversification Opportunities for GlaxoSmithKline PLC and Meitav Trade

-0.89
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GlaxoSmithKline and Meitav is -0.89. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Meitav Trade Inv in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Meitav Trade Inv and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Meitav Trade. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Meitav Trade Inv has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Meitav Trade go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Meitav Trade

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Meitav Trade. But the stock apears to be less risky and, when comparing its historical volatility, GlaxoSmithKline PLC ADR is 1.12 times less risky than Meitav Trade. The stock trades about -0.23 of its potential returns per unit of risk. The Meitav Trade Inv is currently generating about 0.69 of returns per unit of risk over similar time horizon. If you would invest  961.00  in Meitav Trade Inv on September 1, 2024 and sell it today you would earn a total of  184.00  from holding Meitav Trade Inv or generate 19.15% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy85.71%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Meitav Trade Inv

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Meitav Trade Inv 

Risk-Adjusted Performance

41 of 100

 
Weak
 
Strong
Excellent
Compared to the overall equity markets, risk-adjusted returns on investments in Meitav Trade Inv are ranked lower than 41 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Meitav Trade sustained solid returns over the last few months and may actually be approaching a breakup point.

GlaxoSmithKline PLC and Meitav Trade Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Meitav Trade

The main advantage of trading using opposite GlaxoSmithKline PLC and Meitav Trade positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Meitav Trade can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Meitav Trade will offset losses from the drop in Meitav Trade's long position.
The idea behind GlaxoSmithKline PLC ADR and Meitav Trade Inv pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets